How artificial intelligence is being used to monitor neurodegenerative diseases and dementia

Watch the video explaining the neurosurgeon Nicollas Nunes Rabelo

An article was published in the scientific journal Nature brought the Altoida test results. And what is it about? The exam Altoida is able to distinguish preclinical Alzheimer’s disease from prodromal Alzheimer’s disease (when signs and symptoms appear) to a level currently unattainable with conventional standard (pen and paper) tests.

Altoida is a non-invasive test that uses digital biomarkers, immersive augmented reality and artificial intelligence to detect neurodegenerative diseases and dementia, such as Alzheimer’s, as well as cognitive disorders.

It was also useful to evaluate the forgetfulness caused by the consequences of Covid19. In the case of women, it can also evaluate forgetfulness caused by hormonal problems, such as mental confusion.

The test is non-invasive and does not emit radiation. Use a tablet and immersive augmented reality. During the exam, the person virtually hides the objects, taking advantage of the space he is in. Then you have time to search. It also does eye tracking and can measure the speed and pressure of touching the screen. Also evaluate the person’s walk.

Watch the video with neurosurgeon Nicollas Nunes Rabelo.

HOMEWORKS

inspires transformation in the world of work, in business, in society. Compasso, a content and connection agency, is born.

Source: Terra

Ben

Ben Stock is a lifestyle journalist and author at Gossipify. He writes about topics such as health, wellness, travel, food and home decor. He provides practical advice and inspiration to improve well-being, keeps readers up to date with latest lifestyle news and trends, known for his engaging writing style, in-depth analysis and unique perspectives.